Sale!

Chr 15q11 Gene Angelman Syndrome Genetic Test

Original price was: $700.Current price is: $500.

-29%

The Chr 15q11 Gene Angelman Syndrome NGS Genetic DNA Test is a cutting-edge diagnostic tool that utilizes Next-Generation Sequencing technology to detect abnormalities in the 15q11 chromosomal region associated with Angelman Syndrome. This comprehensive test identifies genetic mutations, deletions, and imprinting defects that cause this rare neurological disorder characterized by developmental delays, speech impairment, and movement disorders. Priced at $500 USD, the test provides crucial information for accurate diagnosis, treatment planning, and genetic counseling. Results are typically available within 3-4 weeks from blood or DNA samples. Early detection through this advanced genetic analysis can significantly improve patient outcomes and family planning decisions.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Chr 15q11 Gene Angelman Syndrome NGS Genetic DNA Test

Comprehensive Genetic Testing for Angelman Syndrome

The Chr 15q11 Gene Angelman Syndrome NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering unparalleled accuracy in detecting one of the most complex neurodevelopmental disorders. Angelman Syndrome affects approximately 1 in 12,000 to 20,000 individuals and requires sophisticated genetic analysis for proper diagnosis and management.

What is Angelman Syndrome?

Angelman Syndrome is a rare genetic disorder primarily affecting the nervous system, characterized by severe developmental delays, speech impairment, movement and balance problems, and a unique behavioral profile. The condition results from abnormalities in the UBE3A gene located on chromosome 15q11.2-q13, which plays a crucial role in brain development and function.

What This Test Measures and Detects

Our advanced NGS (Next-Generation Sequencing) technology provides comprehensive analysis of the critical 15q11 chromosomal region, detecting:

  • Deletions in the maternal chromosome 15q11.2-q13 region (70-75% of cases)
  • Paternal uniparental disomy (UPD) of chromosome 15 (2-3% of cases)
  • Imprinting defects affecting gene expression (3-5% of cases)
  • UBE3A gene mutations (10% of cases)
  • Chromosomal rearrangements and microdeletions

Who Should Consider This Test

Clinical Indications and Symptoms

This test is recommended for individuals presenting with the following symptoms:

  • Developmental delay noticeable by 6-12 months of age
  • Severe speech impairment with minimal or no use of words
  • Movement or balance disorders including ataxia and tremors
  • Frequent laughter and smiling with an apparent happy demeanor
  • Seizures, typically beginning between 2-3 years of age
  • Microcephaly (small head size)
  • Sleep disturbances and feeding difficulties in infancy
  • Hyperactive behavior with short attention span
  • Fascination with water and crinkly materials

Benefits of Taking the Test

Early and accurate diagnosis through our comprehensive genetic testing provides numerous advantages:

  • Accurate Diagnosis: Eliminates diagnostic uncertainty and prevents misdiagnosis
  • Personalized Treatment: Enables targeted therapeutic interventions and management strategies
  • Genetic Counseling: Provides crucial information for family planning and recurrence risk assessment
  • Early Intervention: Facilitates timely access to specialized therapies and educational support
  • Medical Management: Guides appropriate seizure control and sleep management protocols
  • Family Support: Connects families with specialized support networks and resources

Understanding Your Test Results

Interpretation Guidance

Our comprehensive genetic report includes detailed interpretation of your results:

  • Positive Result: Confirms Angelman Syndrome diagnosis, allowing for immediate implementation of appropriate care plans
  • Negative Result: Excludes Angelman Syndrome, directing further diagnostic evaluation toward other conditions
  • Variant of Uncertain Significance: Requires additional family studies and clinical correlation
  • Carrier Status: Provides information about recurrence risks for future pregnancies

All results are reviewed by board-certified genetic specialists and accompanied by detailed genetic counseling to ensure complete understanding and appropriate next steps.

Test Details and Pricing

Test Component Details
Test Name Chr 15q11 Gene Angelman Syndrome NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Methodology Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure optimal testing outcomes, we require:

  • Complete clinical history of the patient
  • Genetic counseling session to create a detailed family pedigree
  • Documentation of affected family members with similar symptoms
  • Informed consent for genetic testing

Nationwide Accessibility

We have diagnostic centers conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network ensures that advanced genetic testing is accessible to families nationwide.

Take the Next Step Toward Diagnosis

Don’t let diagnostic uncertainty delay appropriate care and support. Our specialized team of genetic counselors and neurologists is ready to help you navigate this important testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book the Chr 15q11 Gene Angelman Syndrome NGS Genetic DNA Test.

Early diagnosis through comprehensive genetic testing can make a significant difference in quality of life and treatment outcomes. Take control of your genetic health journey with our expert team and state-of-the-art diagnostic capabilities.